Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2015

Open Access 01-12-2015 | Meeting abstract

Clinical features of diabetes mellitus in hereditary pancreatitis

Authors: Marcio Garrison Dytz, Pedro Arthur Hamamoto Marcelino, Ana Luiza Campanholo, Isabella Albuquerque Pinto Rebello, Flavia Lucia Conceição, Tânia Maria Ortiga-Carvalho, Lenita Zajdenverg, Melanie Rodacki

Published in: Diabetology & Metabolic Syndrome | Special Issue 1/2015

Login to get access

Excerpt

Hereditary pancreatitis (HP) is a rare autosomal dominant disease characterized by recurrent acute pancreatitis that progresses to chronic pancreatitis. Common clinical manifestations are abdominal pain, disabsorptive syndrome due to exocrine dysfunction and diabetes mellitus (DM) due to damage to islet cells. …
Metadata
Title
Clinical features of diabetes mellitus in hereditary pancreatitis
Authors
Marcio Garrison Dytz
Pedro Arthur Hamamoto Marcelino
Ana Luiza Campanholo
Isabella Albuquerque Pinto Rebello
Flavia Lucia Conceição
Tânia Maria Ortiga-Carvalho
Lenita Zajdenverg
Melanie Rodacki
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue Special Issue 1/2015
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-7-S1-A107

Other articles of this Special Issue 1/2015

Diabetology & Metabolic Syndrome 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine